🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great opportunity to hear of the pioneering work that has lead to the first 100% adoption #AIinNHS #savingbrains NHS England Professor Stephen Powis Stroke Association British & Irish Association of Stroke Physicians Getting It Right First Time (GIRFT) Kiruba Nagaratnam Darrien Bold Health Innovation Oxford & Thames Valley George Harston

🗞️An Exploration of Serious Falls After #Stroke Using a Large International Stroke Rehabilitation Database 📊Data from AVERT 🧍1 in 25 experienced serious falls 👇Read more below: journals.sagepub.com/doi/full/10.11…

MeVO trials 🧠Mica Schachter, MD 🇺🇲🇦🇷 #ISC25 Stroke AHA/ASA Casey Albin, MD Luciano Sposato 🇦🇷🇨🇦 Richard Choi, DO, FNCS Jimmy Suh, MD Jay Dolia MD Sitara Koneru, MD Giana Dawod, MD Jennifer Harris Rachel Forman Shadi Yaghi Alexandra Czap Alianza Joven Latinoamericana contra el ACV Andreas Charidimou MD, PhD Jim Siegler (@jimsieglermd.bsky.social now) SVIN Dan Harrison, MD #stroke @neurology

🚑🏥New study suggests benefit of EVT compared to medical management does not vary by interhospital-transfer status 🧠Study in acute anterior-circulation large vessel occlusion patients with large infarcts Read more here!👇 journals.sagepub.com/doi/abs/10.117…

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial - The Lancet thelancet.com/journals/lance…

‘there is a strong safety-based rationale for a single universal switch to tenecteplase 0.25 mg/kg for all acute ischemic stroke thrombolysis incl off-label use: wake-up/unknown onset/late time window cases who fulfill the MRI or CTP criteria’ journals.sagepub.com/doi/full/10.11…

🚨 New expert insights on dyslipidemia in #EHJPharmacotherapy! 📝 This expert opinion highlights how combining therapies can improve patient outcomes and optimize lipid control using simple algorithms 🩺 📖 Read more: ow.ly/jpOa50VeAOU EHJ-CVP Editor-in-Chief Felice Gragnano

Our expert panel will share insights from the most successful AI roll-out in acute care across the NHS and the role of our evaluation & implementation programme. Contributors include Darrien Bold David Hargroves 💙 Kiruba Nagaratnam George Harston Gary Ford Tracey Marriott. 2/3

A simplified definition of a statin-eligible primary prevention patient is one who is: • 40–70 years old w/ LDL-C ≥ 3.0 mmol/L or • 55–80 years old with LDL-C ≥ 1.8 mmol/L & additional risk factors 💊 ow.ly/K6vm50Vhffm EJHF Editor-in-Chief Jan Biegus #HFA_ESC #ESCHeartFailure

Finally, the first and the largest #metaanalysis on the #upfront combination #lipid lowering therapy (#LLT) of moderate to high intensity #statin #therapy and #ezetimibe vs statin monotherapy has been released in the Mayo Clinic Proceedings‼️ Based on the data from 14 studies with

#ISCHEMIA trial update! Hitting #GDMT goals early (BP<130, LDL<70, no smoking, antiplatelets) = major CV event reduction! Are we doing enough to optimize therapy? 🔗 Full #JACC study: jacc.org/doi/10.1016/j.… #Cardiology

Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke jamanetwork.com/journals/jama/…

Outcomes Following Minimally Invasive Surgery for Intracerebral Hemorrhage in the AHA Get With The Guidelines Registry | Stroke ahajournals.org/doi/abs/10.116…

Catch up with the latest webinars, news, views and opportunities in our April newsletter: mailchi.mp/healthinnovati… Sign up to receive our newsletter and other communications: …hinnovationoxford.us7.list-manage.com/subscribe?u=51…

Just Accepted! 💊Compared to those on standard antiplatelet treatment, those on combined treatment (addition of oral anticoagulant to antiplatelet) had: 👉Similar risk of ischemic stroke recurrence ☝️Higher risk of major hemorrhage Read more here👇 journals.sagepub.com/doi/abs/10.117…

Just stopped for a coffee 🙂

Professor Martin James provides more insight into how Artificial intelligence (AI) is being used to help improve outcomes for stroke patients. Read more here > bbc.co.uk/news/articles/…

The UK government is promoting a “strategic shift” from “treatment to prevention.” This requires action on wider determinants of health, say Vageesh Jain and Thomas Beaney bmj.com/content/389/bm…

Aspirin Continuation or Discontinuation in Surgically Treated Chronic Subdural Hematoma jamanetwork.com/journals/jaman…

In 2023/24, there were over 135 million outpatient appointments in England. Behind that figure is a story of mounting pressure, wasted time, and missed opportunities. Theresa Barnes looks at how outpatient care has been overlooked in policy and planning bmj.com/content/389/bm…